New Zealand markets closed

Corbus Pharmaceuticals Holdings, Inc. (CRBP)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
58.00+4.97 (+9.37%)
At close: 04:00PM EDT
54.84 -3.16 (-5.45%)
After hours: 06:42PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 566.72M
Enterprise value 463.90M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)5.84
Enterprise value/revenue N/A
Enterprise value/EBITDA 0.17

Trading information

Stock price history

Beta (5Y monthly) 2.59
52-week change 3675.29%
S&P500 52-week change 322.23%
52-week high 361.18
52-week low 33.03
50-day moving average 347.08
200-day moving average 325.93

Share statistics

Avg vol (3-month) 3284.23k
Avg vol (10-day) 3334.66k
Shares outstanding 510.69M
Implied shares outstanding 610.69M
Float 87.04M
% held by insiders 10.87%
% held by institutions 193.34%
Shares short (28 Jun 2024) 4836.94k
Short ratio (28 Jun 2024) 42.42
Short % of float (28 Jun 2024) 49.68%
Short % of shares outstanding (28 Jun 2024) 47.83%
Shares short (prior month 31 May 2024) 4369.11k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:30
Last split date 314 Feb 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024


Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-26.36%
Return on equity (ttm)-59.52%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -36.79M
Net income avi to common (ttm)-33.76M
Diluted EPS (ttm)-6.90
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)120.1M
Total cash per share (mrq)11.24
Total debt (mrq)17.29M
Total debt/equity (mrq)17.83%
Current ratio (mrq)4.69
Book value per share (mrq)9.23

Cash flow statement

Operating cash flow (ttm)-28.95M
Levered free cash flow (ttm)-17.13M